Soft Tissue Sarcoma
The new targeted drug, PLX3397, has demonstrated responses in patients with pigmented villonodular synovitis (PVNS), a rare joint disorder.
Most Popular Right Now
Cixutumumab Plus Temsirolimus Improves PFS and With Encouraging OS for Bone and Soft Tissue SarcomaBy Gary Schwartz, MD, from the Memorial Sloan-Kettering Cancer Center
Read more >>>